FindTrial
Sign In

Application of Tetracaine Hydrochloride Gel in Brachytherapy for Cervical Cancer Patients

Application of Tetracaine Hydrochloride Gel in Brachytherapy for Cervical Cancer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126002
Enrollment
Unknown
Registered
2026-06-02
Start date
2025-12-03
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical carcinoma

Interventions

Experimental group:Five minutes before the procedure, 10g of tetracaine bydrochloride gelly (10g per vial contains 0.10g of tetracaine hydrochloride, Xi'an Lijun Essence Pharmaceutical)was used to moi
Control Group:Routine care and psychological care

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients with pathologically confirmed cervical cancer; 2. Patients requiring brachytherapy; 3. Patients with a total internal radiation dose of 30 Gy (6 Gy per fraction, 5 fractions); 4. Patients with no active vaginal bleeding.

Exclusion criteria

Exclusion criteria: 1. Allergic to lidocaine or amide-type anesthetic drugs 2. Patients with severe vaginal bleeding 3. Patients with communication disorders and inability to cooperate voluntarily

Design outcomes

Primary

MeasureTime frame
Pain scoring;—

Secondary

MeasureTime frame
Operational Cooperation Degree;Pulse change;—

Countries

China

Contacts

Public ContactZhong Wenhuan

Sun Yat-sen University Cancer Center

zhongwh@sysucc.org.cn+86 20 8734 2220

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026